ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Pathos
The Director, CMC – Biologics & ADC will lead the chemistry, manufacturing, and controls strategy for antibody and antibody‑drug conjugate oncology programs, overseeing upstream and downstream process development, analytical development, and ADC manufacturing from early clinical supply through late‑stage development. This foundational hire will build and scale the CMC function, collaborate with cross‑functional teams, and ensure phase‑appropriate quality and regulatory‑ready documentation.
Headquarters
New York, New York, United States
Company Size
11-50 employees
Founded
2022
Pathos is an AI-enabled, clinical-stage biotech company redefining drug development for precision oncology. The company integrates advanced AI technology, biological modeling, and the largest collection of multimodal oncology patient data to make clinical trials smarter, faster, and more precise. By identifying the right patient populations and building a repeatable development engine, Pathos aims to reduce trial failures and accelerate the delivery of precision therapies through biopharma partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pathos.
20% above the average for this role
Associate Director, CMC Team Lead
alnylam
Biologics Process Development Scientific Lead
Merck & Co., Inc.
CMC Professional
Crescent Biopharma
Associate Director Antibody Development United States
alnylam
Biologics Process Development Scientific Lead
MSD
Associate Director, Downstream, Emerging Modalities
alnylam